Study guide
9.7 Immunodeficiency and Oral HIV Manifestations
Overseas Registration Examination ORE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: ORE Part 1 — Exam Blueprint, Logistics and Strategy
1.1 Structure and Format of ORE Part 1 1.2 The Official Blueprint and Preparing for Practice 1.3 Eligibility, Fees, Attempts and Time Limits
2 Chapter 2: Anatomy of the Head and Neck
2.1 The Trigeminal Nerve and Dental Innervation 2.2 The Facial Nerve and Parotid Region 2.3 The Temporomandibular Joint and Muscles of Mastication 2.4 The Infratemporal Fossa and Spread of Odontogenic Infection
3 Chapter 3: Dental Anatomy, Morphology and Occlusion
3.1 Permanent and Primary Tooth Morphology 3.2 Functional Occlusion: Centric Relation, Guidance and Interferences 3.3 Classifying Occlusion: Angle and BSI Incisor Relationships
4 Chapter 4: Genetics, Embryology and Odontogenesis
4.1 Stages of Odontogenesis and Molecular Signalling 4.2 Amelogenesis and Enamel Microstructure 4.3 Dentinogenesis and the Pulp-Dentine Complex 4.4 Cementum, the Periodontal Ligament and Oral Mucosa 4.5 Genetic and Developmental Dental Anomalies
5 Chapter 5: Oral Biology and Salivary Physiology
5.1 Salivary Gland Anatomy, Microarchitecture and Innervation 5.2 Salivary Secretion, Flow Rates and Autonomic Control 5.3 Salivary Buffering Systems and Protective Macromolecules 5.4 Physiology of Mastication and Deglutition 5.5 Taste, Lingual Papillae and Gustatory Pathways 5.6 Xerostomia, Sjogren's Syndrome and Salivary Diagnostics
6 Chapter 6: Physiology of the Major Body Systems
6.1 Cardiovascular and Respiratory Physiology 6.2 Renal, Endocrine and Gastrointestinal Physiology 6.3 Haematology and Haemostasis 6.4 Neurophysiology, Pain and the Autonomic Nervous System
7 Chapter 7: Bone Biology, Calcium Homeostasis and Healing
7.1 Microstructure and Architecture of Alveolar Bone 7.2 Bone Remodelling and the RANK/RANKL/OPG Axis 7.3 Endocrine Control of Calcium and Phosphate 7.4 Extraction Socket Healing and Ridge Resorption 7.5 Impaired Healing: MRONJ, Osteoradionecrosis and Systemic Risk
8 Chapter 8: Oral Microbiology and Biofilm Ecology
8.1 The Oral Microbiome and Biofilm Development 8.2 Cariogenic Microbiology: Mutans Streptococci and Lactobacilli 8.3 Ecological Hypotheses of Dental Caries 8.4 Biofilm Tolerance and the Case for Mechanical Plaque Control
9 Chapter 9: Immunology Relevant to Oral Disease
9.1 Innate Mucosal Immunity and Gingival Crevicular Fluid 9.2 Cellular Immunity in the Periodontium 9.3 Microbial Pathogenesis: Complexes and Keystone Pathogens 9.4 Host-Mediated Tissue Destruction 9.5 Hypersensitivity Reactions in Dental Practice 9.6 Autoimmune Mucocutaneous Bullous Disease 9.7 Immunodeficiency and Oral HIV Manifestations
10 Chapter 10: General Pathology and Neoplasia
10.1 Cellular Adaptation and Mechanisms of Cell Death 10.2 Inflammation, Wound Healing and Repair 10.3 Principles of Neoplasia and Carcinogenesis 10.4 TNM Staging of Oral Cavity Carcinoma
11 Chapter 11: Statistics and Research Methods
11.1 Study Designs and the Hierarchy of Evidence 11.2 Descriptive and Inferential Statistics 11.3 Diagnostic Test Performance 11.4 Critical Appraisal, Bias and Research Governance
12 Chapter 12: Human Disease: Cardiovascular and Respiratory
12.1 Infective Endocarditis and NICE CG64 12.2 Hypertension and Blood Pressure Thresholds for Dental Care 12.3 Angina, Myocardial Infarction and Antiplatelet Therapy 12.4 Asthma, COPD and Respiratory Emergencies
13 Chapter 13: Human Disease: Endocrine, Haematological and Renal
13.1 Diabetes Mellitus and the Periodontal Axis 13.2 Congenital Bleeding and Clotting Disorders 13.3 Anticoagulants and Antiplatelets: The SDCEP Protocol 13.4 Chronic Kidney Disease and Haemodialysis
14 Chapter 14: Human Disease: Gastrointestinal, Hepatic and Neurological
14.1 Gastrointestinal Disease and Intrinsic Dental Erosion 14.2 Liver Disease, Coagulopathy and Viral Hepatitis 14.3 Epilepsy, Stroke and Transient Ischaemic Attack 14.4 Trigeminal Neuralgia, Bell's Palsy and Giant Cell Arteritis
15 Chapter 15: Oral Aspects of Human Disease
15.1 Oral Manifestations of Systemic Disease 15.2 Orofacial Pain and Temporomandibular Disorders 15.3 Dry Mouth, Altered Taste and Halitosis
16 Chapter 16: Infection Prevention and Control
16.1 The Decontamination Cycle, Sterilization and Waterlines 16.2 Routes of Transmission and Blood-Borne Viruses
17 Chapter 17: Dental Materials
17.1 Dental Amalgam: Metallurgy and UK Regulation 17.2 Resin Composites: Chemistry and Placement 17.3 Dental Adhesive Systems 17.4 Acid Etching, the Hybrid Layer and MMP Degradation 17.5 Glass Ionomer Cements, RMGICs and Compomers 17.6 Impression Materials and Digital Scanning 17.7 Luting Cements and Adhesive Conditioning Protocols 17.8 Dental Ceramics and Cast Alloys 17.9 Gypsum Products, Waxes and Denture Base Polymers
18 Chapter 18: Behavioural Sciences Relevant to Oral Health Care
18.1 Health Behaviour Models and Behaviour Change 18.2 Dental Anxiety and Phobia 18.3 Psychosocial and Sociological Determinants of Oral Health
19 Chapter 19: Patient Assessment and Diagnosis
19.1 History Taking and Clinical Examination 19.2 Special Investigations and Reaching a Diagnosis
20 Chapter 20: Treatment Planning and Risk-Based Care
20.1 Treatment Planning and Sequencing 20.2 Risk Assessment, Recall Intervals and Preventive Planning
21 Chapter 21: Cariology and Caries Risk Assessment
21.1 Caries Pathogenesis and the Stephan Curve 21.2 Histopathology of Enamel and Dentinal Caries 21.3 Caries Diagnosis, ICDAS and Risk Assessment
22 Chapter 22: Operative Dentistry and Minimal Intervention
22.1 Minimal Intervention and Selective Caries Removal 22.2 Pulp Vitality Assessment and Biological Pulp Capping 22.3 Cavity Design, the C-Factor and Margin Geometry
23 Chapter 23: Endodontics
23.1 Pulp Histology and the Low-Compliance Environment 23.2 Pulpal Neurophysiology and Dentine Hypersensitivity 23.3 Pulpal and Periapical Diagnostic Terminology 23.4 Endodontic Diagnostic Testing 23.5 Access Cavity Design and Canal Configurations 23.6 Working Length Determination and Canal Preparation 23.7 Chemical Disinfection and Irrigant Activation 23.8 Medicaments, Obturation Materials and Techniques 23.9 Restoring Endodontically Treated Teeth 23.10 Endodontic Emergencies, Cracked Teeth and Root Fracture
24 Chapter 24: Periodontology
24.1 The 2018 Classification and Periodontal Health 24.2 Plaque-Induced and Non-Plaque-Induced Gingival Disease 24.3 Staging and Grading Periodontitis 24.4 Peri-Implant Disease and Systemic Risk Factors 24.5 The Basic Periodontal Examination 24.6 Simplified BPE in Children and Full Periodontal Charting 24.7 Furcation Involvement, Mobility and Occlusal Trauma 24.8 The BSP Stepwise Treatment Framework 24.9 Periodontal Instrumentation and Healing 24.10 Re-Evaluation, Endpoints and Periodontal Surgery 24.11 Crown Lengthening, Supracrestal Attachment and Supportive Care
25 Chapter 25: Fixed Prosthodontics
25.1 Biomechanical Principles of Tooth Preparation 25.2 Margin Design and the Supracrestal Attachment 25.3 Bridge Design and Resin-Bonded Bridges 25.4 Gingival Retraction, Provisionals and Temporary Cements
26 Chapter 26: Removable Prosthodontics
26.1 Removable Partial Dentures: Classification, Design and Surveying 26.2 Complete Dentures: Principles, Impressions and Jaw Registration
27 Chapter 27: Paediatric Dentistry
27.1 Primary Tooth Anatomy and Caries Management Strategies 27.2 Preformed Metal Crowns and the Hall Technique 27.3 Pulp Therapy in Primary Teeth 27.4 Extractions in the Primary Dentition 27.5 Non-Pharmacological Behaviour Management 27.6 Inhalation Sedation in Paediatric Dentistry 27.7 The Developing Dentition and Space Management 27.8 Serial Extraction and Non-Nutritive Sucking Habits
28 Chapter 28: Dental Traumatology
28.1 Trauma Assessment and Fractures of Permanent Teeth 28.2 Luxation Injuries, Avulsion and Replantation 28.3 Primary Tooth Trauma and Splinting Specifications
29 Chapter 29: Orthodontics
29.1 Extraoral Orthodontic Assessment 29.2 Intraoral Occlusal Assessment 29.3 Skeletal Pattern and Cephalometric Analysis 29.4 IOTN and NHS Treatment Eligibility 29.5 Upper Removable Appliances 29.6 Functional and Fixed Appliances 29.7 Biology of Orthodontic Tooth Movement 29.8 Orthodontic Risks and Retention
30 Chapter 30: Oral Surgery
30.1 Exodontia Biomechanics and Instrument Selection 30.2 Surgical Flap Design, Bone Removal and Suturing 30.3 Third Molar Surgery and NICE Guidance 30.4 Dry Socket and Oroantral Communication 30.5 Odontogenic Infection and Fascial Space Spread
31 Chapter 31: Oral Medicine
31.1 Recurrent Aphthous Stomatitis 31.2 Oral Candidiasis 31.3 Viral Oral Infections 31.4 Reactive Soft Tissue Lesions and the Epulides 31.5 Oral Potentially Malignant Disorders 31.6 Oral Squamous Cell Carcinoma, Urgent Referral and Biopsy
32 Chapter 32: Oral Pathology
32.1 Odontogenic and Non-Odontogenic Cysts 32.2 Odontogenic Tumours 32.3 Obstructive and Reactive Salivary Gland Disease 32.4 Salivary Gland Neoplasms
33 Chapter 33: Therapeutics and Prescribing
33.1 Local Anaesthetic Chemistry and Mechanism of Action 33.2 UK Local Anaesthetic Formulations 33.3 Vasoconstrictors, Maximum Doses and Systemic Toxicity 33.4 Analgesics for Acute Dental Pain 33.5 Antimicrobial Stewardship and First-Line Regimens 33.6 Antifungal and Antiviral Therapeutics
34 Chapter 34: Medical Emergencies in Dental Practice
34.1 The ABCDE Approach and the Emergency Drug Kit 34.2 Anaphylaxis and Acute Coronary Syndrome 34.3 Hypoglycaemia, Acute Asthma and Seizures 34.4 Syncope, Adrenal Crisis, Choking and Resuscitation
35 Chapter 35: Dental Radiology and Radiation Protection
35.1 Radiation Physics, Filtration and Collimation 35.2 Intraoral, Bitewing and Occlusal Projections 35.3 Dental Panoramic Tomography: Principles, Positioning and Errors 35.4 Lateral Cephalometry and Cone Beam CT 35.5 Systematic Reporting and Radiographic Caries Diagnosis 35.6 Radiology of Periodontal Bone Loss and Jaw Lesions 35.7 Radiographic Quality Assurance 35.8 IRR17 and IR(ME)R 2017
36 Chapter 36: Special Care Dentistry and Conscious Sedation
36.1 Special Care Dentistry, Risk Stratification and Sedation Principles 36.2 Inhalation Sedation with Nitrous Oxide 36.3 Intravenous Sedation with Midazolam 36.4 Oral Sedation and General Anaesthesia Referral
37 Chapter 37: Dental Public Health
37.1 Delivering Better Oral Health and the Fluoride Toolkit 37.2 Oral Health Epidemiology and Indices 37.3 Inequalities, Water Fluoridation and Population Prevention 37.4 NHS Dental Services, Access and Commissioning
38 Chapter 38: Communication and Interpersonal Skills
38.1 Patient Communication and Shared Decision-Making 38.2 Breaking Bad News, Complaints and the Duty of Candour 38.3 Referrals, Records and Communication with the Team
39 Chapter 39: Consent and Capacity
39.1 Valid Consent and the Montgomery Standard 39.2 The Mental Capacity Act 2005 39.3 Best Interests Decisions and Lasting Power of Attorney 39.4 Consent in Children and Young People 39.5 Safeguarding Children and Vulnerable Adults 39.6 Confidentiality, Data Protection and Lawful Disclosure
40 Chapter 40: Clinical Professionalism and the GDC
40.1 The General Dental Council and Standards Principles 1 to 4 40.2 GDC Standards: Principles 5 to 9 40.3 The GDC Fitness to Practise Process 40.4 Clinical Governance and the Audit Cycle
41 Chapter 41: Health and Safety Law in Dental Practice
41.1 Health and Safety Legislation, COSHH, RIDDOR and Sharps
42 Chapter 42: Self-Management and Professional Development
42.1 Enhanced CPD, Lifelong Learning and Reflective Practice 42.2 Managing Time, Stress and Clinical Wellbeing 42.3 Leadership, Delegation and Practice Management
9.7 Immunodeficiency and Oral HIV Manifestations
Key Takeaways Explain This Topic AI
Severe combined immunodeficiency, X-linked agammaglobulinaemia and Chediak-Higashi syndrome all present with rampant early-onset periodontal destruction.
HIV gp120 binds CD4 with CCR5 or CXCR4 co-receptors; a CD4 count below 200 cells per microlitre defines AIDS.
Pseudomembranous candidiasis wipes away with gauze leaving an erythematous base, whereas oral hairy leukoplakia does not.
Oral hairy leukoplakia is Epstein-Barr virus driven, sits on the lateral tongue border and has no malignant potential.
Linear gingival erythema is a persistent 2 to 3 mm fiery red band along the free gingival margin that does not respond to plaque removal alone.
Last updated: September 2026
- 3. Immunodeficiencies: Primary Disorders and Secondary HIV Manifestations
- Primary Immunodeficiencies (Congenital)
Severe Combined Immunodeficiency (SCID): Heterogeneous genetic disorders characterised by absent or dysfunctional T and B lymphocytes. The most common form is X-linked SCID , caused by mutations in the IL2RG gene encoding the common gamma chain (γc) shared by cytokine receptors for IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Lack of IL-7 signaling arrests T-cell development, while lack of IL-15 arrests natural killer (NK) cell development. Clinically presents within the first months of life with intractable diarrhea, failure to thrive, persistent pseudomembranous oral candidiasis, and fatal opportunistic pulmonary infections ( Pneumocystis jirovecii ).
X-Linked Agammaglobulinaemia (Bruton's Disease): Mutation in the BTK gene on the X chromosome encoding Bruton tyrosine kinase . BTK is essential for B-cell maturation beyond the pre-B stage. Affected males have virtually zero circulating mature B lymphocytes (CD19+, CD20+) and a profound deficiency of all immunoglobulin classes (IgG, IgA, IgM, IgE). T-cell immunity remains intact. Patients become susceptible to recurrent pyogenic infections caused by encapsulated bacteria ( Streptococcus pneumoniae , Haemophilus influenzae ) starting at 6 months of age, following the physiological clearance of transplacentally acquired maternal IgG.
Chediak-Higashi Syndrome: Autosomal recessive disorder caused by mutations in the LYST (lysosomal trafficking regulator) gene. Disrupted vesicular trafficking produces abnormal, giant cytoplasmic lysosomal granules in all granulated cells, including neutrophils, melanocytes, and platelets. Neutrophils exhibit severe defects in chemotaxis and delayed phagolysosomal degranulation. Clinically characterised by partial oculocutaneous albinism , recurrent pyogenic infections, peripheral neuropathy, and rampant, aggressive, early-onset periodontitis causing premature loss of all deciduous and permanent teeth.
Secondary Immunodeficiencies: Human Immunodeficiency Virus (HIV / AIDS)
HIV is an enveloped retrovirus possessing two identical single-stranded RNA molecules. The viral envelope glycoprotein gp120 binds to the CD4 receptor on host helper T cells, macrophages, and dendritic cells, inducing a conformational change that enables secondary binding to chemokine coreceptors ( CCR5 in macrophage-tropic strains; CXCR4 in T-cell-tropic strains). Subsequently, viral gp41 mediates fusion of the viral envelope with the host membrane. Progressive viral replication depletes CD4+ T lymphocytes, collapsing cell-mediated immunity. An absolute CD4 count <200 cells/μL (or a CD4 percentage <14%) defines the diagnosis of AIDS .
Oral Manifestations of HIV Infection
Oral lesions are among the earliest, most sensitive clinical biomarkers of HIV infection, tracking viral load and CD4 decline: ORAL MANIFESTATIONS OF HIV
- │
- ┌───────────────────────────────┼──────────────────────────────┐
- ▼ ▼ ▼
- [Fungal Infections] [Viral Infections] [Periodontal / Neoplastic]
- Pseudomembranous Candidiasis • Oral Hairy Leukoplakia • Linear Gingival Erythema (LGE)
- Erythematous Candidiasis (EBV; non-malignant) • Necrotising Periodontitis (NUP)
- Angular Cheilitis • Kaposi Sarcoma (HHV-8) • Non-Hodgkin Lymphoma (EBV)
Oral Candidiasis: The most common intraoral opportunistic infection in HIV, occurring in over 85–90% of untreated AIDS patients:
Pseudomembranous (Thrush): Creamy white, curd-like plaques on the labial/buccal mucosa, tongue, and soft palate. Composed of fungal hyphae, desquamated epithelial cells, and necrotic debris. Characteristically wipes away with dry gauze , leaving a raw, erythematous, or bleeding base.
Erythematous (Atrophic): Presents as smooth, fiery red macules or depapillated atrophic patches, characteristically on the hard palate and dorsum of the tongue . Frequently overlooked because it lacks the classic white plaques of thrush. It is a highly sensitive clinical harbinger of severe immunosuppression.
Angular Cheilitis: Erythema, maceration, and fissuring radiating from the oral commissures, frequently representing a mixed infection ( Candida albicans and Staphylococcus aureus ).
Oral Hairy Leukoplakia (OHL): Caused by opportunistic replication of Epstein-Barr Virus (EBV / HHV-4) within the spinous keratinocytes of the oral epithelium. Clinically presents as non-wipeable, asymptomatic, corrugated, vertically folded or "hairy" white plaques located almost exclusively on the lateral borders of the tongue (unilateral or bilateral). Histologically displays hyperparakeratosis, epithelial acanthosis, and upper prickle cells displaying nuclear clearing and peripheral chromatin beading ("koilocyte-like" ballooning cells). Crucially, OHL has zero malignant potential and does not require surgical excision; it serves as a clinical biomarker of disease progression and typically resolves upon initiation of effective antiretroviral therapy (ART).
Kaposi Sarcoma (KS): A malignant vascular neoplasm driven by Human Herpesvirus 8 (HHV-8 / KSHV) . It is the most common intraoral malignancy in HIV/AIDS. Most commonly affects the hard palate (>50% of intraoral lesions) and attached gingiva. Lesions begin as asymptomatic flat, red, purple, or brown macules that evolve into elevated, spongy, vascular plaques and large, lobulated, exophytic masses that bleed easily on mastication. Histology reveals proliferating fascicles of spindle-shaped endothelial cells surrounding slit-like vascular channels with extravasated erythrocytes and hemosiderin pigment.
Linear Gingival Erythema (LGE): A distinctive form of gingivitis presenting as a persistent, continuous 2–3 mm fiery red band along the free and attached gingival margin. It occurs independently of plaque levels and fails to resolve with conventional scaling and improved oral hygiene alone . Subgingival colonization by Candida species is heavily implicated; therapy requires chlorhexidine rinses and topical antifungals.
Necrotising Periodontal Diseases (NUG and NUP):
Necrotising Ulcerative Gingivitis (NUG): Acute, excruciatingly painful condition characterised by necrosis and ulceration of the interdental papillae ("punched-out", crater-like papillae) covered by a friable grayish pseudomembrane, spontaneous gingival haemorrhage, and intense fetor oris .
Necrotising Ulcerative Periodontitis (NUP): Rapid progression of necrosis involving the periodontal ligament and alveolar bone. Produces catastrophic, deep osseous destruction, tooth mobility, and exposure of necrotic bone sequestra within days to weeks. Associated with an anaerobic fusospirochaetal complex ( Treponema spp., Prevotella intermedia , Fusobacterium nucleatum ).
Management: Gentle debridement with warm saline / ultrasonic instrumentation, chemical biofilm suppression with 0.2% chlorhexidine or 1.5% hydrogen peroxide mouthwashes, systemic metronidazole (400 mg three times daily for 3–5 days) , pain management, and urgent communication with the patient's HIV physician.
- 4. Clinical Application: Worked Examples and Traps
- Clinical Trap: Inappropriate Prescribing for Suspected "Denture Stomatitis"
A common diagnostic error is assuming all palatal erythema beneath a maxillary complete denture represents benign Newton Type II denture-related stomatitis. If the patient is young, does not wear a denture, or if the palatal erythema is accompanied by weight loss or generalized lymphadenopathy, the practitioner must suspect erythematous candidiasis secondary to undiagnosed HIV infection or severe immunosuppression. Direct questioning regarding risk factors, full medical review, and referral for serological HIV screening are warranted.
Worked Clinical Example
Scenario: A 64-year-old female is referred by her general dental practitioner with a 6-month history of painful, "bleeding gums". Clinical examination reveals generalized fiery red desquamative gingivitis involving the labial and lingual attached gingiva of both arches, along with two intact tense bullae on the hard palate. Routine gentle brushing causes superficial mucosal detachment. The patient also mentions that her eyes have felt "gritty and dry" for the past three weeks.
Diagnostic & Treatment Protocol:
Clinical Suspicion: The presence of tense intraoral bullae, desquamative gingivitis, and ocular grittiness points strongly to Mucous Membrane Pemphigoid (MMP) .
Diagnostic Biopsy: Perform two perilesional punch biopsies:
Specimen A (in 10% neutral buffered formalin for light microscopy): Expect subepithelial clefting at the BMZ with an intact, full-thickness epithelial roof and an absence of acantholysis.
Specimen B (in Michel's transport medium for Direct Immunofluorescence): Expect a continuous linear band of IgG and C3 strictly along the basement membrane zone.
Immediate Clinical Action: Instigate an immediate, urgent referral to an ophthalmologist for baseline slit-lamp evaluation. Early subconjunctival cicatrization must be identified to prevent symblepharon formation and irreversible blindness.